Cargando…

Herpes Virus Amplicon Vectors

Since its emergence onto the gene therapy scene nearly 25 years ago, the replication-defective Herpes Simplex Virus Type-1 (HSV-1) amplicon has gained significance as a versatile gene transfer platform due to its extensive transgene capacity, widespread cellular tropism, minimal immunogenicity, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Silva, Suresh, Bowers, William J.
Formato:	Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783652/ https://www.ncbi.nlm.nih.gov/pubmed/19956558 http://dx.doi.org/10.3390/v1030594

Ejemplares similares

Multigene human artificial chromosome vector delivery with herpes simplex virus 1 amplicons
por: Chan, David YL, et al.
Publicado: (2020)

Silencing Status Epilepticus-Induced BDNF Expression with Herpes Simplex Virus Type-1 Based Amplicon Vectors
por: Falcicchia, Chiara, et al.
Publicado: (2016)

Enhanced Production of Herpes Simplex Virus 1 Amplicon Vectors by Gene Modification and Optimization of Packaging Cell Growth Medium
por: Fernández-Frías, Iván, et al.
Publicado: (2020)

Development and Assessment of Herpes Simplex Virus Type 1 (HSV-1) Amplicon Vectors with Sensory Neuron-Selective Promoters
por: Joussain, Charles, et al.
Publicado: (2022)

Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System
por: Artusi, Sara, et al.
Publicado: (2018)

Transfer of Anti-Rotavirus Antibodies during Pregnancy and in Milk Following Maternal Vaccination with a Herpes Simplex Virus Type-1 Amplicon Vector
por: Meier, Anita F., et al.
Publicado: (2017)

Herpes Simplex Virus Type 1/Adeno-Associated Virus Hybrid Vectors
por: de Oliveira, Anna Paula, et al.
Publicado: (2010)

Functional Overexpression of Vomeronasal Receptors Using a Herpes Simplex Virus Type 1 (HSV-1)-Derived Amplicon
por: Stein, Benjamin, et al.
Publicado: (2016)

Human cytomegalovirus plasmid-based amplicon vector system for gene therapy
por: Mahmood, Kutubuddin, et al.
Publicado: (2005)

Herpes Simplex and Pseudorabies Viruses
por: Hierholzer, Walter J.
Publicado: (1970)

Clinical Management of Herpes Simplex Virus Keratitis
por: Labib, Bisant A., et al.
Publicado: (2022)

Evaluation of parameters for efficient purification and long-term storage of herpes simplex virus-based vectors
por: Kuroda, Seiji, et al.
Publicado: (2022)

Herpes Simplex Virus Infection in Pregnancy
por: Straface, Gianluca, et al.
Publicado: (2012)

Designing herpes viruses as oncolytics
por: Peters, Cole, et al.
Publicado: (2015)

Mucosal Herpes Immunity and Immunopathology to Ocular and Genital Herpes Simplex Virus Infections
por: Chentoufi, Aziz Alami, et al.
Publicado: (2012)

Constitutive and Inducible Innate Responses in Cells Infected by HSV-1-Derived Amplicon Vectors
por: Tsitoura, Eliza, et al.
Publicado: (2010)

Pathogenesis and virulence of herpes simplex virus
por: Zhu, Shuyong, et al.
Publicado: (2021)

Herpes and polyoma family viruses in thyroid cancer
por: STAMATIOU, DIMITRIS P., et al.
Publicado: (2016)

Retargeting Strategies for Oncolytic Herpes Simplex Viruses
por: Campadelli-Fiume, Gabriella, et al.
Publicado: (2016)

Immunological control of herpes simplex virus infections
por: Egan, Kevin P., et al.
Publicado: (2013)

Advances in Alpha Herpes Viruses Vaccines for Human
por: Preda, Madalina, et al.
Publicado: (2023)

A Sequel to Sanger: amplicon sequencing that scales
por: Hebert, Paul D. N., et al.
Publicado: (2018)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
por: Ulaszewska, Marta, et al.
Publicado: (2023)

Induction of humoral responses to BHV-1 glycoprotein D expressed by HSV-1 amplicon vectors
por: Blanc, Andrea Maria, et al.
Publicado: (2012)

Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients
por: Tayyar, Ralph, et al.
Publicado: (2023)

Innate and Adaptive Immune Responses to Herpes Simplex Virus
por: Chew, Tracy, et al.
Publicado: (2009)

The molecular basis of herpes simplex virus latency
por: Nicoll, Michael P, et al.
Publicado: (2012)

Exploiting Herpes Simplex Virus Entry for Novel Therapeutics
por: Hadigal, Satvik, et al.
Publicado: (2013)

Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs
por: Braidwood, Lynne, et al.
Publicado: (2013)

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
por: Aldrak, Norah, et al.
Publicado: (2021)

DEN-IM: dengue virus genotyping from amplicon and shotgun metagenomic sequencing
por: Mendes, Catarina I., et al.
Publicado: (2020)

Novel Amplicon-Based Sequencing Approach to West Nile Virus
por: Diagne, Moussa Moïse, et al.
Publicado: (2023)

Immune Response to Herpes Simplex Virus Infection and Vaccine Development
por: Ike, Anthony C., et al.
Publicado: (2020)

Herpes Virus Fusion and Entry: A Story with Many Characters
por: Eisenberg, Roselyn J., et al.
Publicado: (2012)

Herpes Simplex Virus 2 ICP0(−) Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine
por: Halford, William P., et al.
Publicado: (2010)

Evasion of Early Antiviral Responses by Herpes Simplex Viruses
por: Suazo, Paula A., et al.
Publicado: (2015)

Are herpes virus associated to aggressive periodontitis? A review of literature
por: Rodrigues, Patrícia Maria de Sousa, et al.
Publicado: (2015)

Herpes simplex virus and varicella zoster virus, the house guests who never leave
por: Kinchington, Paul R, et al.
Publicado: (2012)

Herpes simplex and herpes zoster viruses in COVID-19 patients
por: Katz, Joseph, et al.
Publicado: (2021)

Epidemiology of herpes simplex virus type 1 and genital herpes in Australia and New Zealand: systematic review, meta-analyses and meta-regressions
por: AlMukdad, Sawsan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6lj1upgh8hhh7ei9ruher8780s